prostaglandin E2 Archives
Diabetes, cardiovascular drug targets
May. 24, 2022—Targeting receptors of the inflammatory lipid signaling molecule PGE2 may offer a new way to tackle both Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.
Searching out pancreatic cancer risk
Dec. 7, 2017—Vanderbilt researchers have identified a biomarker that could be used to predict pancreatic cancer risk.